Pfizer
Mrs. Serra completed a post-graduate research project on the global epidemiology of staphylococcus and enterococcus resisting to antibiotics at the Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA, Portugal), before receiving her degree in Biotechnology from the Universidade Nova de Lisboa, Portugal. She is currently a Senior Director in the Pfizer Biopharmaceutical Group working directly with Emerging Markets and China where she is a Scientific Affairs Expert and Medical Affairs Lead for their meningococcal vaccines. Mrs. Serra has worked at Pfizer for nearly 18 years and in the past 10 years has dedicated her work to better understand meningococcal disease and meningococcal vaccines.

Moderator Of 1 Session

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Session Description
Taking control over Meningococcal Disease: Is now the time? - Symposium Supported by PfizerSession Description:This symposium will:•Appeal for support for the WHO Roadmap on defeating meningitis •Highlight the effects of vaccination in S America •Show how IMD can be prevented and the need for more comprehensive vaccines

Presenter Of 4 Presentations

Live Q&A

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Lecture Time
12:05 PM - 12:30 PM

Welcome and introduction

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Lecture Time
11:00 AM - 11:05 AM

Defeating meningitis in the COVID-19 era

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Lecture Time
11:05 AM - 11:20 AM

Conclusion

Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Lecture Time
12:00 PM - 12:05 PM